There are minimal reports of temozolomide-induced DRESS syndrome. The diagnosis can be life-threatening, which makes the glioblastoma treatment with no alternative treatment option challenging. The use of temozolomide desensitization has been proposed for the management of severe adverse cutaneous drug reactions 1).